These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 33716989)
1. Vitamin D Association With Macrophage-Derived Cytokines in Polycystic Ovary Syndrome: An Enhanced Risk of COVID-19 Infection? Moin ASM; Sathyapalan T; Butler AE; Atkin SL Front Endocrinol (Lausanne); 2021; 12():638621. PubMed ID: 33716989 [TBL] [Abstract][Full Text] [Related]
2. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China. Wang L; Lv S; Li F; Yu X; Bai E; Yang X Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394 [No Abstract] [Full Text] [Related]
3. A Cross-Sectional Exploratory Study of Cardiovascular Risk Biomarkers in Non-Obese Women with and without Polycystic Ovary Syndrome: Association with Vitamin D. Nandakumar M; Das P; Sathyapalan T; Butler AE; Atkin SL Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928037 [TBL] [Abstract][Full Text] [Related]
4. Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome. Li HW; Brereton RE; Anderson RA; Wallace AM; Ho CK Metabolism; 2011 Oct; 60(10):1475-81. PubMed ID: 21550088 [TBL] [Abstract][Full Text] [Related]
5. Vitamin D association with the renin angiotensin system in polycystic ovary syndrome. Butler AE; Moin ASM; Sathyapalan T; Atkin SL J Steroid Biochem Mol Biol; 2021 Nov; 214():105965. PubMed ID: 34619249 [TBL] [Abstract][Full Text] [Related]
6. Vitamin D deficiency effects on cardiovascular parameters in women with polycystic ovary syndrome: A retrospective, cross-sectional study. Butler AE; Dargham SR; Abouseif A; El Shewehy A; Atkin SL J Steroid Biochem Mol Biol; 2021 Jul; 211():105892. PubMed ID: 33785436 [TBL] [Abstract][Full Text] [Related]
7. Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study. Subramanian A; Anand A; Adderley NJ; Okoth K; Toulis KA; Gokhale K; Sainsbury C; O'Reilly MW; Arlt W; Nirantharakumar K Eur J Endocrinol; 2021 May; 184(5):637-645. PubMed ID: 33635829 [TBL] [Abstract][Full Text] [Related]
8. Vitamin D levels and lipid profiles in patients with polycystic ovary syndrome. Moieni A; Haghollahi F; Dashtkoohi M; Abiri A; Salari E; Najafi MS; Tajik N BMC Womens Health; 2024 Aug; 24(1):472. PubMed ID: 39192256 [TBL] [Abstract][Full Text] [Related]
9. Inflammatory Markers in Non-Obese Women with Polycystic Ovary Syndrome Are Not Elevated and Show No Correlation with Vitamin D Metabolites. Moin ASM; Sathyapalan T; Atkin SL; Butler AE Nutrients; 2022 Aug; 14(17):. PubMed ID: 36079796 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the association of vitamin D deficiency with gonadotropins and sex hormone in obese and non-obese women with polycystic ovary syndrome. Velija-Ašimi Z Med Glas (Zenica); 2014 Feb; 11(1):170-6. PubMed ID: 24496360 [TBL] [Abstract][Full Text] [Related]
11. Classical and alternate complement factor overexpression in non-obese weight matched women with polycystic ovary syndrome does not correlate with vitamin D. Moin ASM; Sathyapalan T; Butler AE; Atkin SL Front Endocrinol (Lausanne); 2022; 13():935750. PubMed ID: 36619572 [TBL] [Abstract][Full Text] [Related]
12. Vitamin D Deficiency among Adolescent Females with Polycystic Ovary Syndrome. Sadhir M; Kansra AR; Menon S J Pediatr Adolesc Gynecol; 2015 Oct; 28(5):378-81. PubMed ID: 26209866 [TBL] [Abstract][Full Text] [Related]
13. Comparison of 25-hydroxyvitamin D and metabolic parameters between women with and without polycystic ovarian syndrome. Ng BK; Lee CL; Lim PS; Othman H; Ismail NAM Horm Mol Biol Clin Investig; 2017 Jun; 31(3):. PubMed ID: 28586302 [TBL] [Abstract][Full Text] [Related]
14. Associations between vitamin D levels and polycystic ovary syndrome phenotypes. Davis EM; Peck JD; Hansen KR; Neas BR; Craig LB Minerva Endocrinol; 2019 Jun; 44(2):176-184. PubMed ID: 29652114 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities. Figurová J; Dravecká I; Javorský M; Petríková J; Lazúrová I Wien Klin Wochenschr; 2016 Sep; 128(17-18):641-8. PubMed ID: 25787215 [TBL] [Abstract][Full Text] [Related]
16. Genotype-independent association between vitamin D deficiency and polycystic ovarian syndrome in Lahore, Pakistan. Lone NM; Riaz S; Eusaph AZ; Mein CA; Wozniak EL; Xenakis T; Wu Z; Younis S; Jolliffe DA; Junaid K; Martineau AR Sci Rep; 2020 Feb; 10(1):2290. PubMed ID: 32042037 [TBL] [Abstract][Full Text] [Related]
17. Apa-I polymorphism in VDR gene is related to metabolic syndrome in polycystic ovary syndrome: a cross-sectional study. Santos BR; Lecke SB; Spritzer PM Reprod Biol Endocrinol; 2018 Apr; 16(1):38. PubMed ID: 29669566 [TBL] [Abstract][Full Text] [Related]
18. Coronavirus Disease 2019 (SARS-CoV-2) and polycystic ovarian disease: Is there a higher risk for these women? Morgante G; Troìa L; De Leo V J Steroid Biochem Mol Biol; 2021 Jan; 205():105770. PubMed ID: 33065278 [TBL] [Abstract][Full Text] [Related]
19. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Wehr E; Pilz S; Schweighofer N; Giuliani A; Kopera D; Pieber TR; Obermayer-Pietsch B Eur J Endocrinol; 2009 Oct; 161(4):575-82. PubMed ID: 19628650 [TBL] [Abstract][Full Text] [Related]
20. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance. Naderpoor N; Shorakae S; Abell SK; Mousa A; Joham AE; Moran LJ; Stepto NK; Spritzer PM; Teede HJ; de Courten B J Steroid Biochem Mol Biol; 2018 Mar; 177():209-215. PubMed ID: 28734987 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]